Financing Through Stock Acquisition Rights with a Variable Exercise Price
First written in FY2019-Q1. 25 of 32 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2027-H1.
20 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Series 6 stock acquisition rights Series 7 stock acquisition rights Resolution date 7 August 2026 Number of stock acquisition rights (units) 7,500 7,500 Class, details and number of underlying shares (shares) Common shares 750,000 Common shares 750,000 Initial exercise price ¥1,198 ¥1,198 Exercise period 25 August 2026 to 24 August 2029 25 August 2026 to 24 August 2029 Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the interim accounting period 270 Shares delivered upon exercise during the interim accounting period 27,000 Funds raised through exercise during the interim accounting period ¥29.976 million」
The company established a new financing program by issuing 7,500 Series 6 and 7,500 Series 7 stock acquisition rights, covering a total of 1,500,000 shares. Of the Series 6 rights, 270 were exercised, 27,000 shares were delivered, and ¥29.976 million was raised. - FY2026-H1SoftenedAnnual report
「At a meeting of the Board of Directors held on 29 July 2025, the company resolved to acquire and immediately cancel all of the remaining Series 4 stock acquisition rights issued on 8 November 2023, effective 13 August 2025. On 13 August 2025, the company acquired and cancelled all 7,500 remaining Series 4 stock acquisition rights.」
The company acquired and cancelled all 7,500 remaining Series 4 stock acquisition rights, ending the related financing program. - FY2025-H1AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the interim accounting period 2,200 Shares delivered upon exercise during the interim accounting period 220,000 Average exercise price and other details during the interim accounting period ¥586.4 Funds raised through exercise during the interim accounting period ¥129.024 million Cumulative number exercised as of the interim period-end 5,000 Cumulative shares delivered as of the interim period-end 500,000 Cumulative funds raised as of the interim period-end ¥276.398 million」
During the interim accounting period, 2,200 Series 3 stock acquisition rights were exercised, 220,000 shares were delivered, and ¥129.024 million was raised. Cumulative exercise totaled 5,000 rights and cumulative funds raised totaled ¥276.398 million. - FY2025-Q1AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter: 1,513; shares delivered upon exercise during the quarter: 151,300; average exercise price and other details during the quarter: ¥576.1; funds raised through exercise during the quarter: ¥87.165 million.」
Exercise of Series 3 stock acquisition rights during the first quarter resulted in the delivery of 151,300 shares and raised ¥87.165 million. Cumulative totals were 4,313 rights, 431,300 shares and ¥234.538 million. - FY2024AdvancedAnnual report
「Series 3 stock acquisition rights: number exercised during the period, 1,980; shares delivered upon exercise during the period, 198,000; funds raised through exercise during the period, ¥104.515 million.」
During the full year, 2,800 Series 3 stock acquisition rights were exercised, 280,000 shares were delivered, and ¥147.373 million was raised. As of the fiscal year-end, there had been no exercise of the Series 4 or Series 5 stock acquisition rights. - FY2024-Q3AdvancedAnnual report
「The stock acquisition rights issued during the third quarter accounting period were as follows. Series 3 stock acquisition rights / Series 4 stock acquisition rights / Series 5 stock acquisition rights Resolution date: 23 October 2023 Number of stock acquisition rights (units): 5,000 / 7,500 / 7,500 Class, details and number of underlying shares (shares): common shares / 500,000 / 750,000 / 750,000 Initial exercise price: ¥571 / ¥750 / ¥900 Exercise period: 9 November 2023 to 6 November 2026」
The company issued Series 3 through Series 5 stock acquisition rights with exercise price adjustment provisions, establishing a new financing program covering a total of 20,000 rights and 2 million common shares. During the third quarter accounting period, 820 Series 3 rights were exercised, 82,000 shares were delivered, and ¥42.857 million was raised. - FY2024-Q1AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter: 1,523; shares delivered upon exercise during the quarter: 152,300; average exercise price and other details during the quarter: ¥414.3; funds raised through exercise during the quarter: ¥63.096 million; cumulative number exercised as of the quarter-end: 20,000; cumulative shares delivered as of the quarter-end: 2,000,000; cumulative average exercise price and other details as of the quarter-end: ¥464.4; cumulative funds raised as of the quarter-end: ¥928.867 million」
During the quarter, 1,523 stock acquisition rights were exercised, 152,300 shares were delivered, and ¥63.096 million was raised. Cumulative exercise totaled 20,000 rights, cumulative shares delivered totaled 2,000,000, and cumulative funds raised totaled ¥928.867 million. - FY2023AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the period: 6,569 / shares delivered upon exercise during the period: 656,900 / funds raised through exercise during the period: ¥279.666 million / cumulative number exercised as of the period-end: 18,477 / cumulative shares delivered as of the period-end: 1,847,700 / cumulative funds raised as of the period-end: ¥865.771 million」
During the fourth quarter, 6,569 stock acquisition rights were exercised, 656,900 shares were delivered, and ¥279.666 million was raised. Full-year cumulative exercise and funds raised for the Series 2 stock acquisition rights totaled 18,477 rights, 1,847,700 shares and ¥865.771 million. - FY2023-Q3AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter 4,655 Shares delivered upon exercise during the quarter 465,500 Average exercise price and other details during the quarter ¥465.1 Funds raised through exercise during the quarter ¥216.510 million Cumulative number exercised as of the quarter-end 11,908 Cumulative shares delivered as of the quarter-end 1,190,800 Cumulative average exercise price and other details as of the quarter-end ¥492.2 Cumulative funds raised as of the quarter-end ¥586.105 million」
During the third quarter accounting period, 4,655 stock acquisition rights were exercised, 465,500 shares were delivered, and ¥216.510 million was raised. Cumulative totals were 11,908 rights, 1,190,800 shares and ¥586.105 million. - FY2023-Q2AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter 6,490 Shares delivered upon exercise during the quarter 649,000 Average exercise price and other details during the quarter ¥510.4 Funds raised through exercise during the quarter ¥331.250 million Cumulative number exercised as of the quarter-end 7,253 Cumulative shares delivered as of the quarter-end 725,300 Cumulative average exercise price and other details as of the quarter-end ¥509.6 Cumulative funds raised as of the quarter-end ¥369.594 million」
During the second quarter accounting period, 6,490 stock acquisition rights were exercised, 649,000 shares were delivered, and ¥331.250 million was raised. Cumulative totals were 7,253 rights, 725,300 shares and ¥369.594 million. - FY2023-Q1AdvancedAnnual report
「During the first quarter consolidated accounting period, the stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions were exercised as follows. First quarter accounting period (1 March 2022 to 31 May 2022) Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter 763 Shares delivered upon exercise during the quarter 76,300 Funds raised through exercise during the quarter ¥38.344 million」
During the first quarter, 763 stock acquisition rights were exercised, 76,300 shares were delivered, and ¥38.344 million was raised. The company disclosed exercise results for the first time for the Series 2 stock acquisition rights, for which payment of the issue price was completed on 11 May 2022. - FY2022AdvancedAnnual report
「(Issuance of stock acquisition rights) At a meeting of the Board of Directors held on 25 April 2022, the company resolved to issue Series 2 stock acquisition rights through a third-party allotment, with provisions for exercise price adjustment and a suspension request (the “Series 2 Stock Acquisition Rights”). Payment in full of the total issue price of these stock acquisition rights was completed on 11 May 2022.」
Following the exercise and cancellation of the Series 1 stock acquisition rights, the company issued 20,000 Series 2 stock acquisition rights on 11 May 2022 and transitioned to a new financing program expected to raise approximately ¥1,110.2 million in net proceeds. - FY2022-Q3No exercise during the quarterAnnual report
「(3) [Exercise status and other matters concerning bonds and other instruments with stock acquisition rights subject to exercise price adjustment provisions] There are no applicable matters.」
There was no exercise of bonds and other instruments with stock acquisition rights subject to exercise price adjustment provisions during the third quarter accounting period. - FY2021AdvancedAnnual report
「Number of the relevant bonds with subscription rights to shares and other instruments with exercise price adjustment clauses exercised during the period (units) 1,005 / Number of shares delivered upon exercise during the period (shares) 100,500 / Funds raised through exercises during the period (¥ thousands) 46,407 / Cumulative number of the relevant bonds with subscription rights to shares and other instruments with exercise price adjustment clauses exercised as of the end of the period (units) 13,248 / Cumulative number of shares delivered in connection with the relevant bonds with subscription rights to shares and other instruments with exercise price adjustment clauses as of the end of the period (shares) 1,324,800 / Cumulative funds raised through the relevant bonds with subscription rights to shares and other instruments with exercise price adjustment clauses as of the end of the period (¥ thousands) 881,919」
Exercise of the stock acquisition rights with exercise price adjustment provisions progressed during the full year, bringing cumulative funds raised to ¥881.919 million. - FY2021-Q3AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter 1,291 Shares delivered upon exercise during the quarter 129,100 Funds raised through exercise during the quarter ¥58.324 million Cumulative number exercised as of the quarter-end 12,243 Cumulative shares delivered as of the quarter-end 1,224,300 Cumulative funds raised as of the quarter-end ¥835.512 million」
Exercise of stock acquisition rights during the third quarter accounting period raised ¥58.324 million, bringing cumulative funds raised to ¥835.512 million. - FY2021-Q2AdvancedAnnual report
「During the second quarter accounting period, the stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions were exercised as follows: number exercised, 681; shares delivered upon exercise during the quarter, 68,100; and funds raised through exercise during the quarter, ¥31.851 million.」
Exercise of stock acquisition rights with exercise price adjustment provisions during the second quarter accounting period resulted in the delivery of 68,100 shares and raised ¥31.851 million. Cumulative funds raised totaled ¥777.187 million. - FY2020AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the fourth quarter accounting period: 1,216; shares delivered upon exercise during the period: 121,600; funds raised through exercise during the period: ¥80.923 million.」
During the fourth quarter, 1,216 stock acquisition rights were exercised, 121,600 shares were delivered, and ¥80.923 million was raised. Cumulative totals for the 19th fiscal year were 5,461 rights, 546,100 shares and ¥365.291 million. - FY2020-Q3AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter 1,391 Shares delivered upon exercise during the quarter 139,100 Funds raised through exercise during the quarter ¥90.186 million」
During the third quarter accounting period, 1,391 stock acquisition rights with exercise price adjustment provisions were exercised, 139,100 shares were delivered, and ¥90.186 million was raised. - FY2020-Q2AdvancedAnnual report
「During the second-quarter accounting period, stock acquisition rights attached to bonds with adjustment clauses for the exercise price were exercised as follows. Number of such rights exercised during the second-quarter accounting period: 627 Shares delivered upon exercise during the quarter: 62,700 Funds raised through exercises during the quarter: ¥42.432 million」
During the second quarter accounting period, 627 stock acquisition rights with exercise price adjustment provisions were exercised, 62,700 shares were delivered, and ¥42.432 million was raised. Cumulative exercise totaled 7,649 rights and cumulative funds raised totaled ¥573.430 million. - FY2020-Q1AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the quarter 2,227 Shares delivered upon exercise during the quarter 222,700 Funds raised through exercise during the quarter ¥151.749 million」
During the first quarter, 2,227 stock acquisition rights with exercise price adjustment provisions were exercised, 222,700 shares were delivered, and ¥151.749 million was raised. Cumulative exercise totaled 7,022 rights and cumulative funds raised totaled ¥530.998 million. - FY2019AdvancedAnnual report
「Number of stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions exercised during the fourth quarter accounting period: 1,637; shares delivered upon exercise during the period: 163,700; funds raised through exercise during the period: ¥121.253 million.」
During the fourth quarter, 1,637 stock acquisition rights were exercised, 163,700 shares were delivered, and ¥121.253 million was raised. Full-year cumulative totals were 4,795 rights, 479,500 shares and ¥379.248 million. - FY2019-Q3AdvancedAnnual report
「During the third quarter accounting period, the stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions were exercised as follows: number exercised during the quarter, 1,411; shares delivered upon exercise during the quarter, 141,100; funds raised through exercise during the quarter, ¥111.117 million; cumulative number exercised as of the quarter-end, 3,158; cumulative shares delivered as of the quarter-end, 315,800; and cumulative funds raised as of the quarter-end, ¥257.995 million.」
During the third quarter accounting period, 1,411 stock acquisition rights were exercised, 141,100 shares were delivered, and ¥111.117 million was raised. Cumulative totals were 3,158 rights, 315,800 shares and ¥257.995 million. - FY2019-Q2AdvancedAnnual report
「During the second quarter accounting period, the stock acquisition rights attached to bonds and other instruments with exercise price adjustment provisions were exercised as follows: number exercised, 1,505; shares delivered upon exercise during the quarter, 150,500; and funds raised through exercise during the quarter, ¥126.816 million.」
During the second quarter accounting period, 1,505 stock acquisition rights with exercise price adjustment provisions were exercised, 150,500 shares were delivered, and ¥126.816 million was raised. - FY2019-Q1First statedAnnual report
「The stock acquisition rights issued during the first quarter accounting period were as follows. Number of stock acquisition rights (units): 15,000 Number of shares underlying the stock acquisition rights (shares) (Note 1): 1,500,000 Initial exercise price: ¥992 Exercise period of the stock acquisition rights From 2 May 2018 To 30 April 2021 The minimum exercise price for these stock acquisition rights is ¥451. Minimum amount of funds to be raised if all these stock acquisition rights are exercised (assuming all are exercised at the minimum exercise price stated in 6 above): ¥690.9 million」
The company issued 15,000 stock acquisition rights with an exercise price adjustment provision, covering 1,500,000 underlying shares. The initial exercise price was ¥992, the minimum exercise price was ¥451, and the exercise period ran from 2 May 2018 to 30 April 2021. The minimum amount of funds to be raised if all the rights were exercised was ¥690.9 million.